A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.

BMC Gastroenterol · 2009 · PMC2784472 · PMID 19922649

Europe PMC DOI

hedged sentence

0.0460

closest p · 0.9× alpha

0.0460

boldest claim

The sentences

nearly significantp = 0.046actually significant

GD performed significantly or nearly significantly better than placebo for the following endpoints (Tables 3 , 4 and 5 ): GSRS: abdominal pain subscore (p = 0.046), GSRS: abdominal distension subscore (p = 0.061), and GSRS total score (p = 0.048).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.